Clinical Practice Alert: Chlamydia and Gonorrhea Screening and Treatment
June 20, 2019
Rates of sexually-transmitted diseases (STDs) such as chlamydia trachomatis (CT) and gonorrhea (GC) have reached an all-time high. In the U.S., California leads the nation in reported cases of these STDs. Because persons with CT and GC are often asymptomatic, screening is essential for the early detection and treatment that can prevent reproductive complications including pelvic inflammatory disease (PID), tubal infertility, ectopic pregnancy, and chronic pelvic pain in females and epididymitis in males.
This webinar covers current clinical guidelines for routine and targeted screening, treatment, follow-up, and prevention of CT and GC.
- Understand current guidelines for screening for CT and GC among sexually active women and men
- List the indications for anorectal and oropharyngeal CT/GC screening
- Explain when test-of-cure is indicated
- Identify the proper ICD-10 codes for lab requests and billing information